Data as of Sep 30, 2026, 6:36 AM
Trades Sep 25, 2024 – Mar 3, 2026
Issuer
2 politicians disclosed trades in CRNX (Crinetics Pharmaceuticals, Inc.) between Sep 25, 2024 – Mar 3, 2026.
Trades
5
Politicians
2
Buy vol.
$32.0k
Sell vol.
$8,001
Sector
A sale may close the position; filings are not a live holdings snapshot.
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Gilbert Cisneros | Mar 3, 2026 | 3 | 0 | $24.0k |
| Josh Gottheimer | Mar 19, 2025 | 1 | 1 | $16.0k |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Gilbert Cisneros | Mar 3, 2026 | 3 | 0 | $24.0k |
| Josh Gottheimer | Mar 19, 2025 | 1 | 1 | $16.0k |
| Politician | Traded issuer | Sector | Type | Size | Traded | Trade price | Yesterday | Published | Filed after |
|---|---|---|---|---|---|---|---|---|---|
| Gilbert Cisneros | Crinetics Pharmaceuticals, Inc.CRNX | Healthcare | Purchase | $1k–$15k | Mar 3, 2026 | $40.12 | $84.95 | Apr 7, 2026 | 35 days |
| Gilbert Cisneros | Crinetics Pharmaceuticals, Inc.CRNX | Healthcare | Purchase | $1k–$15k | Apr 17, 2025 | $30.42 | $84.95 | May 6, 2025 | 19 days |
| Josh Gottheimer | Crinetics Pharmaceuticals, Inc.CRNX | Healthcare | Sale | $1k–$15k | Mar 19, 2025 | $34.67 | $84.95 | Apr 10, 2025 | 22 days |
| Gilbert Cisneros | Crinetics Pharmaceuticals, Inc.CRNX | Healthcare | Purchase | $1k–$15k | Jan 29, 2025 | $39.38 | $84.95 | Feb 11, 2025 | 13 days |
| Josh Gottheimer | Crinetics Pharmaceuticals, Inc.CRNX | Healthcare | Purchase | $1k–$15k | Sep 25, 2024 | $50.45 | $84.95 | Oct 3, 2024 | 8 days |
Download CRNX congressional trades (CSV)Every politician who disclosed a trade in this symbol in the current snapshot.
RSS for CRNXNew congressional filings in this symbol, by filing date.
Educated guesstimate only. Filings report ranges, not exact sizes. Share counts use the range midpoint (or 1.5× the floor for “Over $X”) and the closing price on the trade date. Open lots are marked to the latest Yahoo Finance close. Cash dividends and split factors are applied while a reconstructed lot is open. Sales with no matching disclosed buy are treated as closing an unseen lot at the sale price (about $0 P/L on that slice). Bonds and rows without a usable ticker are excluded. This is not actual profit.